Gegia et al., 2013 - Google Patents
Outcomes of children treated for tuberculosis with second-line medications in Georgia, 2009–2011Gegia et al., 2013
View PDF- Document ID
- 5801175860240073112
- Author
- Gegia M
- Jenkins H
- Kalandadze I
- Furin J
- Publication year
- Publication venue
- The International journal of tuberculosis and lung disease
External Links
Snippet
BACKGROUND: Drug-resistant tuberculosis (DR-TB) is a major public threat in countries of the former Soviet Union, including Georgia. There are few studies of pediatric DR-TB cases, especially at a national level. OBJECTIVE: To report the characteristics and treatment …
- 239000003814 drug 0 title abstract description 33
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/5695—Mycobacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gegia et al. | Outcomes of children treated for tuberculosis with second-line medications in Georgia, 2009–2011 | |
| Farahani et al. | The semen microbiome and its impact on sperm function and male fertility: a systematic review and meta‐analysis | |
| Sathiananthamoorthy et al. | Reassessment of routine midstream culture in diagnosis of urinary tract infection | |
| Day et al. | Screening for tuberculosis prior to isoniazid preventive therapy among HIV-infected gold miners in South Africa | |
| Laserson et al. | Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis | |
| Shean et al. | Treatment outcome and follow-up of multidrug-resistant tuberculosis patients, West Coast/Winelands, South Africa, 1992–2002 | |
| Clarivet et al. | Prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae and Mycoplasma genitalium in asymptomatic patients under 30 years of age screened in a French sexually transmitted infections clinic | |
| Taarnhøj et al. | Incidence, risk factors and mortality of tuberculosis in Danish HIV patients 1995-2007 | |
| Ioos et al. | Alternative sputum collection methods for diagnosis of childhood intrathoracic tuberculosis: a systematic literature review | |
| Anand et al. | Tuberculosis in kidney transplant recipients: a case series | |
| Nodieva et al. | Recent nosocomial transmission and genotypes of multidrug-resistant Mycobacterium tuberculosis | |
| Massi et al. | Drug resistance among tuberculosis patients attending diagnostic and treatment centres in Makassar, Indonesia | |
| Trébucq et al. | Prevalence of primary and acquired resistance of Mycobacterium tuberculosis to antituberculosis drugs in Benin after 12 years of short-course chemotherapy | |
| Gler et al. | Multidrug-resistant tuberculosis among previously treated patients in the Philippines | |
| Verma et al. | Multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis strains in geriatrics: an analysis and its implications in tuberculosis control | |
| Park et al. | Treatment outcomes in multidrug-resistant tuberculosis according to pyrazinamide susceptibility | |
| Yoo et al. | Additional role of second washing specimen obtained during single bronchoscopy session in diagnosis of pulmonary tuberculosis | |
| Tao et al. | Trends and characteristics of drug-resistant tuberculosis in rural Shandong, China | |
| Mukherjee et al. | Outcomes of different subgroups of smearpositive retreatment patients under RNTCP in rural West Bengal, India | |
| Pang et al. | Diagnostic dilemma: treatment outcomes of tuberculosis patients with inconsistent rifampicin susceptibility | |
| Lonergan et al. | A case series of patients with black tar heroin-associated necrotizing fasciitis | |
| Mathebula et al. | Improving sputum collection processes to increase tuberculosis case finding among HIV-positive persons in Botswana | |
| Wang et al. | Prevalence of multidrug and extensively drug-resistant tuberculosis in Beijing, China: a hospital-based retrospective study | |
| Clevenbergh et al. | Lymph node tuberculosis in patients from regions with varying burdens of tuberculosis and human immunodeficiency virus (HIV) infection | |
| Schreiber et al. | Tuberculosis retreatment category predicts resistance in hospitalized retreatment patients in a high HIV prevalence area |